Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 215

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Initial Feasibility Study of a New Transcatheter Mitral Prosthesis

Open access
Sorajja, Paul, Moat, Neil, Badhwar, Vinay, Walters, Darren, Paone, Gaetano, Bethea, Brian, Bae, Richard, Dahle, Gry, Mumtaz, Mubashir, Grayburn, Paul, Kapadia, Samir, Babaliaros, Vasilis, Guerrero, Mayra, Satler, Lowell, Thourani, Vinod, Bedogni, Francesco, Rizik, David, Denti, Paolo, Dumonteil, Nicolas, Modine, Thomas, Sinhal, Ajay, Chuang, Michael L., Popma, Jeffrey J., Blanke, Philipp, Leipsic, Jonathon, Muller, David·2019·Journal of the American College of Cardiology

Abstract

BACKGROUND Transcatheter mitral valve replacement (TMVR) is a rapidly evolving therapy. Follow-up of TMVR patients remains limited in duration and number treated. OBJECTIVES The purpose of this study was to examine outcomes with expanded follow-up for the first 100 patients who underwent TMVR with the prosthesis. METHODS The Global Feasibility Study enrolled symptomatic patients with either primary or secondary mitral regurgitation (MR) who were at high or prohibitive surgical risk. The present investigation examines the first 100 patients treated in this study. Clinical outcomes through last clinical follow-up were adjudicated independently. RESULTS In the cohort (mean age 75.4 ± 8.1 years; 69% men), there was a high prevalence of severe heart failure symptoms (66%), left ventricular dysfunction (mean ejection fraction 46.4 ± 9.6%), and morbidities (Society of Thoracic Surgeons Predicted Risk of Mortality, 7.8 ± 5.7%). There were no intraprocedural deaths, 1 instance of major apical bleeding, and no acute conversion to surgery or need for cardiopulmonary bypass. Technical success was 96%. The 30-day rates of mortality and stroke were 6% and 2%, respectively. The 1-year survival free of all-cause mortality was 72.4% (95% confidence interval: 62.1% to 80.4%), with 84.6% of deaths due to cardiac causes. Among survivors at 1 year, 88.5% were New York Heart Association function class I/II, and improvements in 6-min walk distance (p < 0.0001) and quality-of-life measurements occurred (p = 0.011). In 73.4% of survivors, the Kansas City Cardiomyopathy Questionnaire score improved by ≥10 points. CONCLUSIONS In this study of TMVR, which is the largest experience to date, the prosthesis was highly effective in relieving MR and improving symptoms, with an acceptable safety profile. Further study to optimize the impact on long-term survival is needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2018.12.066

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 215

Metadata

Authors
Sorajja, P., Moat, N., Badhwar, V., Walters, D., Paone, G., Bethea, B., Bae, R., Dahle, G., Mumtaz, M., Grayburn, P., Kapadia, S., Babaliaros, V., Guerrero, M., Satler, L., Thourani, V., Bedogni, F., Rizik, D., Denti, P., Dumonteil, N., Modine, T., Sinhal, A., Chuang, M. L., Popma, J. J., Blanke, P., Leipsic, J., & Muller, D.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2019-03
Volume
73
Issue
11
Pages
1250-1260
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2924689918
Cited by
215
References
2
FWCI
22.82
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Initial Feasibility Study of a New Transcatheter Mitral Prosthesis. https://app.cochat.ai/papers/10.1016/j.jacc.2018.12.066
The paper
Sorajja, P., Moat, N., Badhwar, V., Walters, D., Paone, G., Bethea, B., Bae, R., Dahle, G., Mumtaz, M., Grayburn, P., Kapadia, S., Babaliaros, V., Guerrero, M., Satler, L., Thourani, V., Bedogni, F., Rizik, D., Denti, P., Dumonteil, N., . . . Muller, D. (2019). Initial Feasibility Study of a New Transcatheter Mitral Prosthesis. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2018.12.066

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.